Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandwich Adjuvant RT and Ifosfamide in Uterine MMT
NCT00231842Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Feb 2003
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ifosfamide in uterine carcinosarcoma (UCS), sponsored by Montefiore Medical Center. Primary endpoint: Cycles With Hematologic Toxicities at 2 years. Started Feb 2003; status: completed.
02
Drugs
ifosfamide
03
Conditions
uterine carcinosarcoma (UCS)
Beyond the preview
Go deeper on NCT00231842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231842.